Entrada Therapeutics, Inc. · NASDAQ:TRDA
TCG Crossover GP I, LLC's stake in Entrada Therapeutics, Inc. fell to 2.70% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
TCG Crossover GP I, LLC's stake in Entrada Therapeutics, Inc. fell to 2.70%, 1,060,230 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 2.70%
- Shares
- 1,060,230
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP I, LLC | 2.70% | 1,060,230 |
| TCG Crossover Fund I, L.P. | 2.70% | 1,060,230 |
| Chen Yu | 2.70% | 1,060,230 |
Source
Related
- Entrada Therapeutics, Inc.
- TCG Crossover GP I, LLC
- Entrada Therapeutics, Inc. shareholders
- Schedule 13G · TCG Crossover GP I, LLC · Nov 25, 2025
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026